Results

GT Biopharma Inc.

11/30/2021 | Press release | Distributed by Public on 11/30/2021 06:38

GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021